Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study

被引:57
作者
Andersson, Charlotte [1 ,2 ]
Lyass, Asya [1 ,3 ]
Vasan, Ramachandran S. [1 ,4 ]
Massaro, Joseph M. [1 ,5 ]
D'Agostino, Ralph B. [1 ,3 ]
Robins, Sander J. [1 ,2 ]
机构
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[4] Boston Univ, Sch Med, Sect Prevent Med & Cardiol, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
关键词
DENSITY-LIPOPROTEIN CHOLESTEROL; HDL CHOLESTEROL; DISEASE; TRIGLYCERIDES; ASSOCIATION; PROFILE;
D O I
10.1016/j.ahj.2014.08.007
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Blood levels of high low-density lipoprotein cholesterol (LDL-C), high triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-C) have been associated with increased risk of cardiovascular disease (CVD). The long-term comparative CVD risk associated with these 3 major lipid classes in various combinations is, however, unknown. Methods A total of 3,501 participants of the Framingham Offspring Study (mean age 51 +/- 10 years, 56% women) without CVD at baseline were followed up for incident CVD between 1987 and 2011. Participants were grouped according to baseline lipid values into 8 distinct categories to compare the prognostic significance of values within an optimal range to Third Report of the National Cholesterol Educational Program-defined high LDL-C (>130 mg/dL), high TG (>150 mg/dL), and/or low HDL-C (<40 mg/dL) in various combinations using multivariable-adjusted Cox regression models. Results On follow-up (median 20.2 years), 724 (21%) had new-onset CVD. Adjusted for confounders and compared with the group with optimal lipid values, hazards ratios and population-attributable risks (PARs) were as follows: isolated low HDL-C, 1.93 (95% CI 1.37-2.71), PAR = 3.1%; isolated high LDL-C, 1.28 (1.03-1.59), PAR 6.4%; isolated high TG, 1.35 (0.91-1.98), PAR = 1.1% (not significant); low HDL-C and high LDL-C, 1.82 (1.33-2.49), PAR = 3.9%; low HDL-C and high TG, 1.74 (1.28-2.37), PAR = 3.9%; high LDL-C and high TG, 1.52 (1.12-2.07), PAR = 6.4%; and high LDL-C, high TG and low HDL-C 2.28 (1.73-3.02), PAR = 7.5%. Conclusions Aside from isolated hypertriglyceridemia, low levels of HDL-C, high levels of LDL-C, and high levels of TG in any combination were associated with increased risk of CVD.
引用
收藏
页码:878 / +
页数:7
相关论文
共 28 条
[1]
Assmann G, 1998, EUR HEART J, V19, pA2
[2]
Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[3]
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[4]
ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[5]
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis [J].
Briel, Matthias ;
Ferreira-Gonzalez, Ignacio ;
You, John J. ;
Karanicolas, Paul J. ;
Akl, Elie A. ;
Wu, Ping ;
Blechacz, Boris ;
Bassler, Dirk ;
Wei, Xinge ;
Sharman, Asheer ;
Whitt, Irene ;
da Silva, Suzana Alves ;
Khalid, Zahira ;
Nordmann, Alain J. ;
Zhou, Qi ;
Walter, Stephen D. ;
Vale, Noah ;
Bhatnagar, Neera ;
O'Regan, Christopher ;
Mills, Edward J. ;
Bucher, Heiner C. ;
Montori, Victor M. ;
Guyatt, Gordon H. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[6]
HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772
[7]
CORRECTED GROUP PROGNOSTIC CURVES AND SUMMARY STATISTICS [J].
CHANG, IM ;
GELMAN, R ;
PAGANO, M .
JOURNAL OF CHRONIC DISEASES, 1982, 35 (08) :669-674
[8]
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272
[9]
Cupples LA, 1987, SOME RISK FACTORS RE
[10]
General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753